These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38099975)

  • 1. ICD early after myocardial infarction: it is really necessary to wait 40 days before implantation?
    Bellicini MG; Cersosimo A; Cerini M; Bontempi L; Curnis A; Arabia G
    J Interv Card Electrophysiol; 2024 Apr; 67(3):439-441. PubMed ID: 38099975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
    Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
    Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
    Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Piccini JP; Al-Khatib SM; Hellkamp AS; Anstrom KJ; Poole JE; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2011 Mar; 8(3):393-400. PubMed ID: 21109025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To the editor--ICD implantation early after myocardial infarction.
    Selvaraj R; Nair K
    Heart Rhythm; 2011 Jan; 8(1):e1; author reply e2. PubMed ID: 21034857
    [No Abstract]   [Full Text] [Related]  

  • 9. Defibrillator implantation early after myocardial infarction.
    Steinbeck G; Andresen D; Seidl K; Brachmann J; Hoffmann E; Wojciechowski D; Kornacewicz-Jach Z; Sredniawa B; Lupkovics G; Hofgärtner F; Lubinski A; Rosenqvist M; Habets A; Wegscheider K; Senges J;
    N Engl J Med; 2009 Oct; 361(15):1427-36. PubMed ID: 19812399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of sudden cardiac death risk in the very early postmyocardial infarction period.
    Daoud EG; Hummel JD; Rhodes TE
    Curr Opin Cardiol; 2010 May; 25(3):253-61. PubMed ID: 22393566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical challenge of preventing sudden cardiac death immediately after acute ST-elevation myocardial infarction.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1427-37. PubMed ID: 25382137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ICD therapy for the primary prevention of sudden cardiac arrest. The patient after a myocardial infarction].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2010 Jun; 21(2):102-8. PubMed ID: 20552316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The timing of implantable cardioverter-defibrillator implantation in patients with heart failure.
    Al-Majed NS; Ezekowitz JA
    Curr Cardiol Rep; 2012 Jun; 14(3):299-307. PubMed ID: 22426975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.
    Blumer J; Wolber T; Hellermann J; Holzmeister J; Binggeli C; Duru F; Brunckhorst C
    Int Heart J; 2009 May; 50(3):313-21. PubMed ID: 19506335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversy surrounding the best time for ICD implantation after myocardial infarction.
    Tereshchenko LG
    Heart Rhythm; 2013 Jun; 10(6):836-7. PubMed ID: 23459066
    [No Abstract]   [Full Text] [Related]  

  • 17. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial.
    Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Gulizia M; Mangiameli S; Montenero AS; Pedretti RF; Uriarte JA; Sermasi S; Nisam S;
    Europace; 2005 Jul; 7(4):327-37. PubMed ID: 16028343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
    Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice.
    Hioki H; Kozuma K; Kobayashi Y; Ando K; Morino Y; Kishihara J; Ako J; Ikari Y
    Cardiovasc Interv Ther; 2022 Jan; 37(1):53-59. PubMed ID: 34195951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who should receive an implantable cardioverter-defibrillator after myocardial infarction?
    Mountantonakis S; Hutchinson MD
    Curr Heart Fail Rep; 2009 Dec; 6(4):236-44. PubMed ID: 19948092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.